keyword
https://read.qxmd.com/read/37822401/assessment-of-effects-of-low-level-light-therapy-on-scalp-condition-and-hair-growth
#1
JOURNAL ARTICLE
Jin Hee Kim, Hyung Seok Son, Da-Ae Yu, Yong Beom Choe, Yang Won Lee
BACKGROUND: The appearance of the scalp and hair is very important aesthetically regardless of age or sex. Although there are many drugs and treatment methods for scalp problems and hair loss, the treatment response is still insufficient. AIMS AND OBJECTIVES: To evaluate the efficacy of low-level light therapy in a helmet-like device. MATERIALS AND METHODS: This study was designed as a 24-week trial with 50 participants. All participants used a helmet-shaped device emitting 630-690, 820-880, and 910-970 nm light wavelengths, for 20 minutes, daily for 24 weeks...
2023: Indian Journal of Dermatology
https://read.qxmd.com/read/35716835/comorbidities-in-patients-with-central-centrifugal-cicatricial-alopecia-a-retrospective-chart-review-of-53-patients
#2
JOURNAL ARTICLE
Bonnie Leung, Linsey Lindley, Joan Reisch, Donald A Glass, Katherine Ayoade
No abstract text is available yet for this article.
June 15, 2022: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/34709679/alopecia-areata-current-understanding-of-the-pathophysiology-and-update-on-therapeutic-approaches-featuring-the-japanese-dermatological-association-guidelines
#3
REVIEW
Masahiro Fukuyama, Taisuke Ito, Manabu Ohyama
Alopecia areata (AA) is a relatively common nonscarring hairloss disease characterized by an autoimmune response to anagen hair follicles (HFs). Accumulated evidence suggests that collapse of the HF immune privilege subsequent to triggering events, represented by viral infection, leads to autoimmune response in which autoreactive cytotoxic CD8+NKG2D+ T cells mainly target exposed HF autoantigens. AA had been recognized as type 1 inflammatory disease, but recent investigations have suggested some roles of type 2- and Th17-associated mediators in AA pathogenesis...
January 2022: Journal of Dermatology
https://read.qxmd.com/read/34379365/ergonomics-in-follicular-unit-excision-surgery
#4
REVIEW
Jae Hyun Park, Na Rae Kim, Kotchamol Manonukul
BACKGROUND: Concentration and physical strength are essential for the long duration of hair transplant surgery. Because both the patient and the doctor must maintain certain postures for long periods, the importance of ergonomics cannot be understated. AIMS: To review the devices, instruments, and techniques developed for ergonomic follicular unit excision surgery, to present our experience with various ergonomic modifications, and to evaluate the effectiveness of the related devices, novel concepts, and methods...
May 2022: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/33901932/case-series-efficacy-of-a-formulation-containing-selamectin-and-sarolaner-against-naturally-acquired-mite-infestations-demodex-sp-ornithonyssus-bacoti-in-degus-octodon-degus
#5
JOURNAL ARTICLE
Wieland Beck, Florin Hora, Nikola Pantchev
Ectoparasite infestations are not common in degus. Two cases are presented here where use of Stronghold® Plus/Revolution® Plus (selamectin and sarolaner topical solution) was successfully administered to a degu (Octodon degus) for treatment of naturally-occurring mite infesations. Selamectin (Stronghold®/Revolution®) has been demonstrated to be effective against naturally-occurring mite infections in dogs and selamectin is approved for use in dogs for the treatment of sarcoptic mange (caused by Sarcoptes scabiei) at a dose of 6 mg/kg...
May 2021: Veterinary Parasitology
https://read.qxmd.com/read/33836553/intracranial-131i-chtnt-brachytherapy-in-patients-with-deep-seated-glioma-a-single-center-experience-with-10-year-follow-up-from-china
#6
JOURNAL ARTICLE
Ming Zhao, Xiangping Fu, Zhiwen Zhang, Anmin Li, Xiaopeng Wang, Xuexiu Li
OBJECTIVE:  The intracranial brachytherapy has been applied for decades, however, no results with long-term follow-up have been reported. This study investigated the long-term efficiency of intra-tumoral injection of 131 I-chTNT in patients with deep-seated glioma. METHOD:  Thirty-five patients undergoing 131 I-chTNT brachytherapy between December 2004 and May 2009 were enrolled. 131 I-chTNT was injected at a dose of 1.5 mCi/cm3 at an interval of 1 month for consecutive 3 times...
August 2021: Nuklearmedizin. Nuclear Medicine
https://read.qxmd.com/read/32719824/association-of-small-fiber-polyneuropathy-with-three-previously-unassociated-rare-missense-scn9a-variants
#7
JOURNAL ARTICLE
Mary A Kelley, Anne Louise Oaklander
BACKGROUND: Small fiber polyneuropathy (SFN) involves ectopic firing and degeneration of small-diameter, somatic/autonomic peripheral axons. Causes include diabetes, inflammation and rare pathogenic mutations, including in SCN9-11 genes that encode small fiber sodium channels. AIMS: The aim of this study is to associate a new phenotype-immunotherapy-responsive SFN-with rare amino acid-substituting SCN9A variants and present potential explanations. METHODS: A retrospective chart review of two Caucasians with skin biopsy confirmed SFN and rare SCN9A single nucleotide polymorphisms not previously reported in neuropathy...
2020: Canadian Journal of Pain, Revue Canadienne de la Douleur
https://read.qxmd.com/read/31338658/anxiety-in-caregiving-partners-of-breast-cancer-patients
#8
JOURNAL ARTICLE
Friederike Hoellen, Julian Frederik Wagner, Dörte W Lüdders, Achim Rody, Constanze Banz-Jansen
PURPOSE: The aim of the present study was to determine the levels of anxiety of partners of breast cancer patients and to evaluate the differences of anxiety levels between patients and partners according to the stage of treatment, age and education level. METHODS: 57 spouses or domestic partners of breast cancer patients and 148 breast cancer patients participated in this prospective cohort study and filled out the questionnaires including the Spielberger state-trait-anxiety-inventory, as well as questions based on stress-triggering procedures during breast cancer diagnosis and therapy...
October 2019: Archives of Gynecology and Obstetrics
https://read.qxmd.com/read/29872683/quality-of-life-in-mild-and-severe-alopecia-areata-patients
#9
JOURNAL ARTICLE
Robabeh Abedini, Zahra Hallaji, Vahideh Lajevardi, Maryam Nasimi, Mona Karimi Khaledi, Hamid Reza Tohidinik
BACKGROUND: Alopecia areata is a relapsing hair disorder characterized by a sudden hairloss and has a considerable impact on patient's quality of life. The goal of this study was to determine quality of life among patients with mild and severe forms of alopecia areata and compare the two groups. METHODS: During one year, 176 patients (96 mild, 80 severe) were selected and asked to complete Dermatology Life Quality Index (DLQI) questionnaires. RESULTS: Our study revealed that the severe group was predominantly female and had higher amount of unemployment, more prolonged disease duration, unstable disease course and facial involvement...
June 2018: International Journal of Women's Dermatology
https://read.qxmd.com/read/27282434/how-to-reach-emotions-with-psychosomatic-patients-a-case-report
#10
JOURNAL ARTICLE
Gwenaëlle Colaianni, Francoise Poot
Alopecia areata (patchy hairloss) often indicates to the dermatologist the existence of psychological disorders, mostly anxiety and depression. Psychosomatic conditions are usually associated with difficulty in expressing emotions, as is the case in alexithymia, and this difficulty is often seen in patients with alopecia areata. This case study aims to show how to help these patients connect with their emotions and how the somatic symptom can become meaningful by using a unifying approach, which challenges the beliefs, the rules and the interactions of both the individual and the family, as well as the emotions expressed or suppressed...
August 23, 2016: Acta Dermato-venereologica
https://read.qxmd.com/read/24770522/case-for-diagnosis-alopecia-areata-and-congenital-triangular-alopecia
#11
JOURNAL ARTICLE
Lorena Cassia de Carvalho Oliveira, Amanda Rodrigues Miranda, Sebastião Alves Pinto, Mayra Ianhez
A 6 year-old patient began to experience localized hairloss in the right temporal region three years ago. During the first appointment, diagnoses of alopecia areata and congenital triangular alopecia were made. After one year, there was no change. Upon dermatological examination, non-scarring alopecia was noted in the right temporal region, revealing extremely fine and fair hair follicles. A dermoscopy revealed only thin vellus-type hairs. Congenital triangular alopecia is a condition commonly confused with alopecia areata and is thus underdiagnosed...
March 2014: Anais Brasileiros de Dermatologia
https://read.qxmd.com/read/23130269/finasteride-and-sexual-side-effects
#12
JOURNAL ARTICLE
Venkataram Mysore
Finasteride, a 5-alpha reductase inhibitor, widely used in the medical management of male pattern hairloss, has been reported to cause sexual side effects. This article critically examines the evidence available and makes recommendations as to how a physician should counsel a patient while prescribing the drug.
January 2012: Indian Dermatology Online Journal
https://read.qxmd.com/read/21985533/comparison-of-two-shampoos-for-the-treatment-of-canine-malassezia-dermatitis-a-randomised-controlled-trial
#13
RANDOMIZED CONTROLLED TRIAL
L Maynard, C A Rème, S Viaud
OBJECTIVES: Two antimicrobial shampoos for treatment of canine Malassezia dermatitis (CMD) were compared in a prospective, randomised, single-blinded, field clinical trial. METHODS: Sixty-seven dogs with pedal or generalised dermatitis associated with Malassezia overgrowth (MO) were treated with 3% chlorhexidine shampoo (3%CHX) or 2% miconazole-2% chlorhexidine shampoo (2%MIC/CHX) and evaluated for up to 6 weeks until cytological recovery. Pruritus, erythema, papules, greasy seborrhoea, scaling, malodour, excoriations, secondary hairloss, lichenification, hyperpigmentation and lesion extent were each scored on a 0-3 severity scale and combined making an aggregate score...
November 2011: Journal of Small Animal Practice
https://read.qxmd.com/read/21188025/mesotherapy-in-management-of-hairloss-is-it-of-any-use
#14
JOURNAL ARTICLE
Venkataram Mysore
Mesotherapy has received a lot of publicity in the media and internet about its possible role in androgenetic alopecia. However, the subject is controversial in view of lack of documented evidence. This article provides a critical commentary on the use of mesotherapy in the management of androgenetic alopecia.
January 2010: International Journal of Trichology
https://read.qxmd.com/read/20273746/treatment-of-hairloss-with-estrogen
#15
JOURNAL ARTICLE
M A GOLDZIEHER
No abstract text is available yet for this article.
1946: Dermatologica
https://read.qxmd.com/read/14341477/-baldness-and-hairloss
#16
JOURNAL ARTICLE
J W MALI
No abstract text is available yet for this article.
May 29, 1965: Nederlands Tijdschrift Voor Geneeskunde
https://read.qxmd.com/read/11016856/therapeutic-interventions-in-mice-with-chronic-proliferative-dermatitis-cpdm-cpdm
#17
JOURNAL ARTICLE
M J Gijbels, G R Elliott, H HogenEsch, C Zurcher, A van den Hoven, P L Bruijnzeel
Chronic proliferative dermatitis (cpd) is a spontaneous mutation in C57BL/Ka mice (cpdm/cpdm). The dermatitis is characterized by redness, hairloss, scaling, pruritus and histologically by epithelial hyperproliferation, infiltration of eosinophils, macrophages and mast cells. Lesions similar to those in the skin occur in the esophagus and forestomach. In this paper, we describe the effect of drug treatments directed against epidermal hyperproliferation (calcipotriene and etretinate), against inflammation (corticosteroids and dapsone) and against pruritus (loratidine and capsaicin)...
October 2000: Experimental Dermatology
https://read.qxmd.com/read/10425919/uncv-uncovered-a-new-mutation-causing-hairloss-on-mouse-chromosome-11
#18
JOURNAL ARTICLE
S R Li, D P Wang, X L Yu, B S Ge, C E Wang, Y F Lu, J Q Li, N Wu, R F Li, S E Zhu, Z C Zhang, Y F Chen
A pair of mutant mice with a first sparse coat appeared spontaneously in the production stock of BALB/c mice with a normal coat. After being sib-mated, they produced three phenotypes in their progeny: mice with normal hair, mice with a first sparse coat and then a fuzzy coat, and uncovered mice. Genetic studies revealed the mutants had inherited an autosomal monogene that was semi-dominant. By using 11 biochemical loci--Idh, Car2, Mup1, Pgm1, Hbb, Es1, Es10, Gdc, Ce2, Mod1 and Es3--as genetic markers, two-point linkage tests were made...
June 1999: Genetical Research
https://read.qxmd.com/read/9887492/-carboplatin-monotherapy-in-clinical-stage-i-of-seminoma-an-acceptable-alternative
#19
JOURNAL ARTICLE
G Nöst, H Lipsky, E Würnschimmel
Between 1/1990-8/1997 two courses of single agent Carboplatin had been given to 36 patients with clinical stage I seminoma. Within an median follow up period of 52 months (17-88) 29 out of 34 patients were analyzed retrospectively. During this period no recurrences had been noted and nobody of our patients died (0% relapsrate, 100% survival-rate). The Carboplatin-therapy was well tolerated. Myelosuppression after chemotherapy was mild (WHO grade I). The experienced acute toxic side effects (max. grade II WHO) during and after chemotherapy had been nausea (37%), vomiting (14%) and mild hairloss (11%)...
November 1998: Der Urologe. Ausg. A
https://read.qxmd.com/read/8574162/successful-treatment-of-accelerated-and-blastic-phase-of-chronic-myeloid-leukemia-with-high-dose-interferon-alpha-and-hydroxyurea-a-novel-approach
#20
JOURNAL ARTICLE
U Jehn, C Pötscher, V Heinemann
Six patients with either acceleration or blast crisis of transformed chronic myeloid leukemia (CML) were treated with high-dose interferon alpha in combination with hydroxyurea. All patients responded to the treatment by reversal to stable chronic phase. Two of these patients responded repeatedly during their course of disease. Median time for return to chronic phase was 4 weeks. Adverse side-effects such as nausea, vomiting, hairloss, fever, prolonged cytopenia were not observed.
September 1995: Leukemia & Lymphoma
keyword
keyword
86697
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.